Literature DB >> 16274883

Neurotoxicity of nitroxyl: insights into HNO and NO biochemical imbalance.

Sandra J Hewett1, Michael G Espey, Tracy F Uliasz, David A Wink.   

Abstract

Nitroxyl anion (NO-), and/or its conjugate acid, HNO, may be formed in the cellular milieu by several routes under both physiological and pathophysiological conditions. Since experimental evidence suggests that certain reactive nitrogen oxide species can contribute significantly to cerebral ischemic injury, we investigated the neurotoxic potential of HNO/NO- using Angeli's salt (AS), a spontaneous HNO/NO(-)-generating compound. Exposure to AS resulted in a time- and concentration-dependent increase in neural cell death that progressed markedly following the initial exposure. Coadministration of the donor with Tempol (1 mM), a one-electron oxidant that converts NO- to NO, prevented its toxic effect, as did the concomitant addition of Fe(III)TPPS. Media containing various chelators, catalase, Cu/Zn superoxide dismutase, or carboxy-PTIO did not ameliorate AS-mediated neurotoxicity, ruling out the involvement of transition metal complexes, H2O2, O2-, and NO, respectively. A concentration-dependent increase in supernatant protein 3-nitrotyrosine immunoreactivity was observed when cultures were exposed to AS under aerobic conditions, an effect lost in the absence of oxygen. A bell-shaped curve for augmented AS-mediated nitration was observed with increasing Fe(III)TPPS concentration, which contrasted with its linear effect on abating cytotoxicity. Finally, addition of glutamate receptor antagonists, MK-801 (10 microM) and CNQX (30 microM) to the cultures abrogated toxicity when given during, but not following, AS exposure; as did pretreatment with the exocytosis inhibitor, tetanus toxin (300 ng/ml). Taken together, our data suggest that under aerobic conditions, AS toxicity is initiated via HNO/NO- but progresses via secondary excitotoxicity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16274883     DOI: 10.1016/j.freeradbiomed.2005.07.007

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  13 in total

Review 1.  The pharmacology of nitroxyl (HNO) and its therapeutic potential: not just the Janus face of NO.

Authors:  Nazareno Paolocci; Matthew I Jackson; Brenda E Lopez; Katrina Miranda; Carlo G Tocchetti; David A Wink; Adrian J Hobbs; Jon M Fukuto
Journal:  Pharmacol Ther       Date:  2006-11-29       Impact factor: 12.310

2.  New dinitrosyl iron complexes bound with physiologically active dipeptide carnosine.

Authors:  Konstantin B Shumaev; Olga V Kosmachevskaya; Elvira I Nasybullina; Sergey V Gromov; Alexander A Novikov; Alexey F Topunov
Journal:  J Biol Inorg Chem       Date:  2016-11-22       Impact factor: 3.358

Review 3.  Nitroxyl (HNO) for treatment of acute heart failure.

Authors:  Alessia Arcaro; Giuseppe Lembo; Carlo G Tocchetti
Journal:  Curr Heart Fail Rep       Date:  2014-09

4.  Nitroxyl (HNO) reacts with molecular oxygen and forms peroxynitrite at physiological pH. Biological Implications.

Authors:  Renata Smulik; Dawid Dębski; Jacek Zielonka; Bartosz Michałowski; Jan Adamus; Andrzej Marcinek; Balaraman Kalyanaraman; Adam Sikora
Journal:  J Biol Chem       Date:  2014-11-05       Impact factor: 5.157

Review 5.  Therapeutic Potential of Nitroxyl (HNO) Donors in the Management of Acute Decompensated Heart Failure.

Authors:  Barbara K Kemp-Harper; John D Horowitz; Rebecca H Ritchie
Journal:  Drugs       Date:  2016-09       Impact factor: 9.546

Review 6.  Clinical physiology and mechanism of dizocilpine (MK-801): electron transfer, radicals, redox metabolites and bioactivity.

Authors:  Peter Kovacic; Ratnasamy Somanathan
Journal:  Oxid Med Cell Longev       Date:  2010 Jan-Feb       Impact factor: 6.543

7.  Photoinduced release of nitroxyl and nitric oxide from diazeniumdiolates.

Authors:  Sergei V Lymar; Vladimir Shafirovich
Journal:  J Phys Chem B       Date:  2007-05-08       Impact factor: 2.991

8.  Generation of nitroxyl by heme protein-mediated peroxidation of hydroxylamine but not N-hydroxy-L-arginine.

Authors:  Sonia Donzelli; Michael Graham Espey; Wilmarie Flores-Santana; Christopher H Switzer; Grace C Yeh; Jinming Huang; Dennis J Stuehr; S Bruce King; Katrina M Miranda; David A Wink
Journal:  Free Radic Biol Med       Date:  2008-05-03       Impact factor: 7.376

9.  TGF-beta1 reduces the heterogeneity of astrocytic cyclooxygenase-2 and nitric oxide synthase-2 gene expression in a stimulus-independent manner.

Authors:  Mary E Hamby; James A Hewett; Sandra J Hewett
Journal:  Prostaglandins Other Lipid Mediat       Date:  2007-12-08       Impact factor: 3.072

Review 10.  Chemistry and antihypertensive effects of tempol and other nitroxides.

Authors:  Christopher S Wilcox; Adam Pearlman
Journal:  Pharmacol Rev       Date:  2008-12       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.